Furthermore, preclinical studies have revealed that activation of the GHRH receptor signaling pathway can effectively prevent and reverse diastolic dysfunction, fibrosis, and cardiomyocyte hypertrophy, which are key features of HF with preserved ejection fraction (29). This evidence concerns the gene GHRHR and hydrops fetalis.